ScoreWhy is Moberg Pharma AB ?
1
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 29.55%, its profits have fallen by -1019.7%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Moberg Pharma AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Moberg Pharma AB
29.55%
-1.10
54.14%
OMX Stockholm 30
10.97%
0.59
18.59%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
70.81%
EBIT Growth (5y)
-4.22%
EBIT to Interest (avg)
-81.88
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.01
Tax Ratio
20.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.23%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.58
EV to EBIT
-0.44
EV to EBITDA
-0.44
EV to Capital Employed
0.34
EV to Sales
11.57
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-76.27%
ROE (Latest)
-37.48%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
PRE-TAX PROFIT(Q)
At SEK -6.96 MM has Grown at 91.38%
RAW MATERIAL COST(Y)
Fallen by -427.98% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 1.49 times
NET PROFIT(Q)
At SEK -12.76 MM has Grown at 80.21%
-3What is not working for the Company
NET SALES(Q)
At SEK 2.07 MM has Fallen at -33.81%
Here's what is working for Moberg Pharma AB
Pre-Tax Profit
At SEK -6.96 MM has Grown at 91.38%
over average net sales of the previous four periods of SEK -80.75 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (SEK MM)
Net Profit
At SEK -12.76 MM has Grown at 80.21%
over average net sales of the previous four periods of SEK -64.45 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (SEK MM)
Inventory Turnover Ratio
Highest at 1.49 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -427.98% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Moberg Pharma AB
Net Sales
At SEK 2.07 MM has Fallen at -33.81%
over average net sales of the previous four periods of SEK 3.12 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (SEK MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
